The use of biomarkers for the evaluation and treatment of patients with acute coronary syndromes

被引：22

作者：

Saenger, Amy K.

Jaffe, Allan S.

机构：

[1] Mayo Clin, Div Cardiovasc, Rochester, MN 55905 USA

[2] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN 55905 USA

来源：

MEDICAL CLINICS OF NORTH AMERICA | 2007年 / 91卷 / 04期

关键词：

D O I：

10.1016/j.mcna.2007.04.001

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The advent of inexpensive, highly accurate, and predictive markers of myocardial injury inflammation, and hemodynamic stability has revolutionized the evaluation and treatment of patients who have acute coronary syndromes (ACSs). These blood biomarkers require small sample volumes, can be run expeditiously, and provide important information concerning the diagnosis, risk stratification, and treatment of these patients. To understand the use of these markers, one must have some knowledge about what elevations in these markers imply, how they have to be collected and measured to provide reliable information, when to suspect analytic confounds, and what the key values are that impart the diagnostic, prognostic, and therapeutic information. This article discusses these issues, emphasizing what clinicians must know for optimal test use, and then addresses the practical use of these markers in patients who have ACS.

引用

页码：657 / +

页数：26

共 112 条

[71] Case definitions for acute coronary heart disease in epidemiology and clinical research studies - A statement from the AHA council on epidemiology and prevention; AHA Statistics Committee; World Heart Federation Council on epidemiology and prevention; the European Society of Cardiology working group on epidemiology and prevention; Centers for Disease Control and Prevention; and the National Heart, Lung, and Blood Institute [J].

Luepker, RV ;

Apple, FS ;

Christenson, RH ;

Crow, RS ;

Fortmann, SP ;

Goff, D ;

Goldberg, RJ ;

Hand, MM ;

Jaffe, AS ;

Julian, DG ;

Levy, D ;

Manolio, T ;

Mendis, S ;

Mensah, G ;

Pajak, A ;

Prineas, RJ ;

Reddy, S ;

Roger, VL ;

Rosamond, WD ;

Shahar, E ;

Sharrett, AR ;

Sorlie, P ;

Tunstall-Pedoe, H .

CIRCULATION, 2003, 108 (20) :2543-2549

[72] Circulating pregnancy-associated plasma protein A predicts outcome in patients with acute coronary syndrome but no troponin I elevation [J].

Lund, J ;

Qin, QP ;

Ilva, T ;

Pettersson, K ;

Voipio-Pulkki, LM ;

Porela, P ;

Pulkki, K .

CIRCULATION, 2003, 108 (16) :1924-1926

[73] Assessing the requirement for the 6-hour interval between specimens in the American Heart Association classification of myocardial infarction in epidemiology and clinical research studies [J].

MacRae, AR ;

Kavsak, PA ;

Lustig, V ;

Bhargava, R ;

Vandersluis, R ;

Palomaki, GE ;

Yerna, MJ ;

Jaffe, AS .

CLINICAL CHEMISTRY, 2006, 52 (05) :812-818

[74] Elevated troponin I level on admission is associated with adverse outcome of primary angioplasty in acute myocardial infarction [J].

Matetzky, S ;

Sharir, T ;

Domingo, M ;

Noc, M ;

Chyu, KY ;

Kaul, S ;

Eigler, N ;

Shah, PK ;

Cercek, B .

CIRCULATION, 2000, 102 (14) :1611-1616

[75] Gender differences in C-reactive protein concentrations - Confirmation with two sensitive methods [J].

McConnell, JP ;

Branum, EL ;

Ballman, KV ;

Lagerstedt, SA ;

Katzmann, JA ;

Jaffe, AS .

CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2002, 40 (01) :56-59

[76] B-Type natriuretic peptide and renal function in the diagnosis of heart failure: An analysis from the Breathing Not Properly Multinational Study [J].

McCullough, PA ;

Duc, P ;

Omland, T ;

McCord, J ;

Nowak, RM ;

Hollander, JE ;

Herrmann, HC ;

Steg, PG ;

Westheim, A ;

Knudsen, CW ;

Storrow, AB ;

Abraham, WT ;

Lamba, S ;

Wu, AHB ;

Perez, A ;

Clopton, P ;

Krishnaswamy, P ;

Kazanegra, R ;

Maisel, AS .

AMERICAN JOURNAL OF KIDNEY DISEASES, 2003, 41 (03) :571-579

[77] Baseline troponin level: key to understanding the importance of post-PCI troponin elevations [J].

Miller, WL ;

Garratt, KN ;

Burritt, MF ;

Lennon, RJ ;

Reeder, GS ;

Jaffe, AS .

EUROPEAN HEART JOURNAL, 2006, 27 (09) :1061-1069

[78] Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction - Results from a randomized trial [J].

Morrow, DA ;

Cannon, CP ;

Rifai, N ;

Frey, MJ ;

Vicari, R ;

Lakkis, N ;

Robertson, DH ;

Hille, DA ;

DeLucca, PT ;

DiBattiste, PM ;

Demopoulos, LA ;

Weintraub, WS ;

Braunwald, E .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (19) :2405-2412

[79] Cardiac troponin I for stratification of early outcomes and the efficacy of enoxaparin in unstable angina: A TIMI-11B substudy [J].

Morrow, DA ;

Antman, EM ;

Tanasijevic, M ;

Rifai, N ;

de Lemos, JA ;

McCabe, CH ;

Cannon, CP ;

Braunwald, E .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (06) :1812-1817

[80] Prognostic value of serial B-type natriuretic peptide testing during follow-up of patients with unstable coronary artery disease [J].

Morrow, DA ;

de Lemos, JA ;

Blazing, MA ;

Sabatine, MS ;

Murphy, SA ;

Jarolim, P ;

White, HD ;

Fox, KAA ;

Califf, RM ;

Braunwald, E .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 294 (22) :2866-2871

← 3 4 5 6 7 8 9 10 11 12 →